Gerhard T, Strom BL, Eyal N. Pandemic vaccine testing: combining conventional and challenge studies.
Pharmacoepidemiol Drug Saf 2022;
31:710-715. [PMID:
35297119 PMCID:
PMC9313872 DOI:
10.1002/pds.5429]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Revised: 03/09/2022] [Accepted: 03/11/2022] [Indexed: 11/16/2022]
Abstract
Early into COVID, human challenge trials were considered, but usually as alternatives to conventional randomized controlled trials. Instead, assessment of authorized COVID vaccines, of further COVID vaccines, and of vaccines against future pandemics should combine both designs, in five different ways, including a wholly novel one that we elaborate, Viz., combining data from both designs to answer a single question.
Collapse